Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention?
about
Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-BInfluence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats.IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB.Our perception of the mast cell from Paul Ehrlich to now.Mast cell function: a new vision of an old cell.Adapters in the organization of mast cell signaling.Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.Positive and negative regulation of FcepsilonRI-mediated signaling by the adaptor protein LAB/NTALPotential effector and immunoregulatory functions of mast cells in mucosal immunity.Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy.Src-like adaptor protein (SLAP) is upregulated in antigen-stimulated mast cells and acts as a negative regulator.A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria.Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE.Coaggregation of FcepsilonRI with FcgammaRIIB Inhibits Degranulation but Not Induction of Bcl-2 Family Members A1 and Bim in Mast Cells.A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.A chimeric human-cat fusion protein blocks cat-induced allergy.
P2860
Q28360737-BE3522F6-6B54-49BD-A97F-FA26F2A65CD6Q33371093-1DBA993B-CA3E-4118-8E47-C57E704133B7Q33770788-46CA5A05-A7A3-43E0-A807-0B6EFABB3460Q34175861-5ECE6FBB-C95A-4661-B4CA-161AA2E2EDF8Q34430917-2EF941D7-B645-4B74-A3B2-E666C00657A5Q34476441-D9FD4649-8ACD-4F30-A6D5-569ACDB08D6EQ35072220-2FA0B9FE-9F55-464D-84A3-D63BC5142ADFQ36330511-9DE2E746-580A-48CC-A57C-16E93E1C1FADQ36399317-011AC30E-8707-4716-809B-404002BA71F5Q36539857-184566D1-1D65-47E9-9EBD-714634CB17D4Q36727733-138D92B1-6274-440D-96EE-CF856BAB8605Q37199195-1C8486F4-4202-4D1B-9E93-44236243182EQ38779538-85B58177-2D63-4E62-B571-589668809876Q39624915-624ED9C9-E4F8-4EA1-910F-9FC445E9DCE7Q40743965-8FE3430C-06AD-47E5-AC2D-F2FDB259BA0CQ42796981-0E516E30-BC5D-4791-858E-1E11CB13287DQ46483879-4DAA0240-8B47-4EDF-A6B0-AF2858F2683B
P2860
Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention?
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activating and inhibitory sign ...... for therapeutic intervention?
@ast
Activating and inhibitory sign ...... for therapeutic intervention?
@en
Activating and inhibitory sign ...... for therapeutic intervention?
@nl
type
label
Activating and inhibitory sign ...... for therapeutic intervention?
@ast
Activating and inhibitory sign ...... for therapeutic intervention?
@en
Activating and inhibitory sign ...... for therapeutic intervention?
@nl
prefLabel
Activating and inhibitory sign ...... for therapeutic intervention?
@ast
Activating and inhibitory sign ...... for therapeutic intervention?
@en
Activating and inhibitory sign ...... for therapeutic intervention?
@nl
P356
P1476
Activating and inhibitory sign ...... for therapeutic intervention?
@en
P2093
P304
P356
10.1067/MAI.2000.109428
P407
P577
2000-09-01T00:00:00Z